Research graph
References from The evolution of antiepileptic drug development and regulation. Local targets link to admitted publications; unresolved targets remain external evidence.
10.2105/ajph.89.1.98
10.2105/ajph.89.1.98 · External reference
10.1002/tera.1026
10.1002/tera.1026 · External reference
10.1046/j.1528-1157.2001.11201.x
10.1046/j.1528-1157.2001.11201.x · External reference
10.1111/j.1528-1157.2000.tb04605.x
10.1111/j.1528-1157.2000.tb04605.x · External reference
10.1016/s0140-6736(62)91847-0
10.1016/s0140-6736(62)91847-0 · External reference
Expérimentation clinique de l'antiipileptique G 32 883 (Tegretol): résultats portant sur 100 cas observés en trois ans
1964 · External reference
10.1016/s0920-1211(01)00323-0
10.1016/s0920-1211(01)00323-0 · External reference
10.1111/j.1528-1167.2005.00355.x
10.1111/j.1528-1167.2005.00355.x · External reference
10.1212/01.wnl.0000252941.50833.4a
10.1212/01.wnl.0000252941.50833.4a · External reference
10.1016/s0140-6736(04)16942-0
10.1016/s0140-6736(04)16942-0 · External reference
10.1212/wnl.55.2.236
10.1212/wnl.55.2.236 · External reference
10.2165/00003495-200868010-00002
10.2165/00003495-200868010-00002 · External reference
10.1212/wnl.33.3_suppl_1.26
10.1212/wnl.33.3_suppl_1.26 · External reference
10.1046/j.1365-2796.2003.01201.x
10.1046/j.1365-2796.2003.01201.x · External reference
10.4103/0378-6323.16782
10.4103/0378-6323.16782 · External reference
10.1136/bmj.1.4877.1451
10.1136/bmj.1.4877.1451 · External reference
10.1212/01.wnl.0000188819.45330.90
10.1212/01.wnl.0000188819.45330.90 · External reference
10.1097/wco.0b013e32805866fb
10.1097/wco.0b013e32805866fb · External reference
10.1111/j.1600-0404.2009.01311.x
10.1111/j.1600-0404.2009.01311.x · External reference
10.1007/bf03259906
10.1007/bf03259906 · External reference
10.1212/wnl.57.10.1774
10.1212/wnl.57.10.1774 · External reference
Unresolved reference
External reference
Unresolved reference
2007 · External reference
10.1212/wnl.52.8.1540
10.1212/wnl.52.8.1540 · External reference
10.1212/01.wnl.0000123693.82339.fc
10.1212/01.wnl.0000123693.82339.fc · External reference
10.1001/archneur.57.12.1782
10.1001/archneur.57.12.1782 · External reference
10.1016/j.eplepsyres.2005.09.016
10.1016/j.eplepsyres.2005.09.016 · External reference
10.1212/wnl.55.8.1106
10.1212/wnl.55.8.1106 · External reference
10.1212/wnl.62.1.23
10.1212/wnl.62.1.23 · External reference
10.1111/j.1528-1167.2006.00585.x
10.1111/j.1528-1167.2006.00585.x · External reference
10.1212/01.wnl.0000303813.95800.0d
10.1212/01.wnl.0000303813.95800.0d · External reference
Unresolved reference
External reference
Unresolved reference
1881 · External reference
10.1111/j.1365-2125.1989.tb03460.x
10.1111/j.1365-2125.1989.tb03460.x · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Luminal bei Epilepsie
1912 · External reference
10.1136/jnnp.58.1.44
10.1136/jnnp.58.1.44 · External reference
10.1177/003591576505800503
10.1177/003591576505800503 · External reference
10.1016/0887-8994(86)90074-3
10.1016/0887-8994(86)90074-3 · External reference
10.1177/000992288402301201
10.1177/000992288402301201 · External reference
10.1097/wco.0b013e3282f4e978
10.1097/wco.0b013e3282f4e978 · External reference
10.1111/j.1528-1157.1978.tb04506.x
10.1111/j.1528-1157.1978.tb04506.x · External reference
Determination of tolerability, safety, and efficacy of perampanel, a selective AMPA receptor antagonist, as adjunctive therapy in subjects with refractory partial epilepsy
2009 · External reference
10.1007/s11940-008-0027-8
10.1007/s11940-008-0027-8 · External reference
10.1046/j.1528-1157.2001.04501.x
10.1046/j.1528-1157.2001.04501.x · External reference
10.1212/wnl.59.6_suppl_4.s38
10.1212/wnl.59.6_suppl_4.s38 · External reference
10.1136/jnnp.67.6.716
10.1136/jnnp.67.6.716 · External reference
Guidelines for treating epilepsy in the age of felbamate, vigabatrin, lamotrigine, and gabapentin
1994 · External reference
Klinische Missbildüngen nach Medikament: einnahme Während der Gravidität?
1961 · External reference
10.1016/j.eplepsyres.2008.09.006
10.1016/j.eplepsyres.2008.09.006 · External reference
Clinical experience with new antiepileptic drugs: antiepileptic drugs in Europe
1999 · External reference
Klinische Erfahrungen mit einem neuen Antiepilepticum, Tegretol (G 32 883) mit besonderer Wirkung auf die epileptische Wesenveränderung
1963 · External reference
10.1007/s11065-007-9043-9
10.1007/s11065-007-9043-9 · External reference
10.1038/bjp.2008.198
10.1038/bjp.2008.198 · External reference
10.1056/nejm198507183130303
10.1056/nejm198507183130303 · External reference
10.1056/nejm199209103271104
10.1056/nejm199209103271104 · External reference
10.1016/s0140-6736(61)90927-8
10.1016/s0140-6736(61)90927-8 · External reference
Sodium diphenyl hydantoinate in the treatment of convulsive disorders
1938 · External reference
10.1111/j.1528-1157.1997.tb01486.x
10.1111/j.1528-1157.1997.tb01486.x · External reference
10.1517/13543784.8.10.1663
10.1517/13543784.8.10.1663 · External reference
10.1016/s0920-1211(03)00080-9
10.1016/s0920-1211(03)00080-9 · External reference
Unresolved reference
External reference
10.1016/j.nurt.2006.11.003
10.1016/j.nurt.2006.11.003 · External reference
10.1182/blood-2007-10-117457
10.1182/blood-2007-10-117457 · External reference
10.1136/jnnp.72.3.412
10.1136/jnnp.72.3.412 · External reference
10.2165/00023210-200216100-00004
10.2165/00023210-200216100-00004 · External reference
10.1046/j.1471-4159.1995.64010462.x
10.1046/j.1471-4159.1995.64010462.x · External reference
10.1371/journal.pmed.0050166
10.1371/journal.pmed.0050166 · External reference
10.2165/00003088-197904030-00001
10.2165/00003088-197904030-00001 · External reference
10.1016/j.eplepsyres.2006.02.004
10.1016/j.eplepsyres.2006.02.004 · External reference
10.1016/s0304-3940(00)00866-1
10.1016/s0304-3940(00)00866-1 · External reference
10.1111/j.0013-9580.2004.11403.x
10.1111/j.0013-9580.2004.11403.x · External reference
10.1517/14740338.3.6.655
10.1517/14740338.3.6.655 · External reference
10.1002/hlca.19540370211
10.1002/hlca.19540370211 · External reference
10.1016/0920-1211(93)90011-u
10.1016/0920-1211(93)90011-u · External reference
A European registry of antiepileptic drug use in patients with Lennox‐Gastaut syndrome
2009 · External reference
Unresolved reference
2006 · External reference
10.1111/j.1528-1157.2000.tb00323.x
10.1111/j.1528-1157.2000.tb00323.x · External reference
10.1111/j.1528-1167.2009.02041.x
10.1111/j.1528-1167.2009.02041.x · External reference
10.1111/j.1528-1167.2009.02042.x
10.1111/j.1528-1167.2009.02042.x · External reference
10.1093/brain/awh363
10.1093/brain/awh363 · External reference
10.1136/bmj.2.4582.769
10.1136/bmj.2.4582.769 · External reference
10.1081/clt-120014645
10.1081/clt-120014645 · External reference
Thrombocytopenia associated with carbamazepine: a case series
1991 · External reference
10.1111/j.1479-828x.2007.00781.x
10.1111/j.1479-828x.2007.00781.x · External reference
10.1684/epd.2007.0144
10.1684/epd.2007.0144 · External reference
10.1111/j.1528-1167.2007.01133.x
10.1111/j.1528-1167.2007.01133.x · External reference
10.1192/bjp.11.56.598-b
10.1192/bjp.11.56.598-b · External reference
10.1016/s0887-8994(02)00505-2
10.1016/s0887-8994(02)00505-2 · External reference
